Tag: Coronavirus information (COVID-19)
Clinical Trials
Kintor Pharmaceutical’s COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment
Kintor Pharmaceutical Limited is delighted to announced that the clinical trial of anti-androgen treatment Proxalutamide (GT0918) for the novel coronavirus disease (COVID-19) has reached...
Clinical Trials
Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International COVID-19 Trial
The Global Coalition for Adaptive Research (GCAR) in collaboration with Amgen and Eisai Co., Ltd., announced enrollment of the first patient in the immune...
Clinical Trials
Baxter Supports New Study Showing Blood Purification with Oxiris Filter Set Can Play a Role in the Management of Severely Ill COVID-19 Patients
Baxter International Inc., a global leader in acute care, recognizes the findings of a prospective, multicenter, observational study on data from the OxirisNet Registry...
Press Releases
Sanofi, GSK to support COVAX with 200mn doses of Covid-19 vaccine
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled...
Press Releases
Cipla launches ‘ELIFast’ (IgG ELISA test) for COVID-19 antibody detection
Cipla Limited announced the commercialisation of antibody detection kits for COVID-19 in India. In partnership with KARWA Ltd. under the technology transfer from the...
Press Releases
Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 to Japan
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, confirmed that...
News
Lilly to Supply 300,000 Vials of Neutralizing Antibody Bamlanivimab in an Effort to Fight COVID-19
Eli Lilly and Company announced an initial agreement with the U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555) 700 mg, an investigational neutralizing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read